Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 13/20 | 0.35 |
| ▸ | USP1 | O94782 | 1/20 | 0.33 |
| ▸ | WDR48 | Q8TAF3 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.30 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10271087 | 0.84 | OPRM1 (0.39) | OPRM1OPRL1 | |
| SCHEMBL20793868 | 0.83 | HRH3 (0.37) | OPRM1OPRL1 | |
| SCHEMBL10119950 | 0.82 | OPRM1 (0.38) | MAP3K12CCR8OPRM1OPRL1 | |
| SCHEMBL24337673 | 0.81 | SHBG (0.36) | MAP3K12USP1WDR48CCR8 | |
| SCHEMBL24851549 | 0.80 | OPRM1 (0.37) | OPRM1OPRL1 | |
| SCHEMBL23961360 | 0.80 | HRH3 (0.35) | — | |
| SCHEMBL25594650 | 0.77 | OPRM1 (0.48) | OPRM1OPRL1 | |
| SCHEMBL19523125 | 0.77 | USP1 (0.34) | MAP3K12USP1WDR48 | |
| SCHEMBL21266983 | 0.76 | SHBG (0.44) | OPRM1OPRL1 | |
| SCHEMBL19368984 | 0.75 | MAP3K12 (0.32) | MAP3K12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3896064-A1 | 4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS CANCER OSAKA THYROID (COT) MODULATORS FOR TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS | Gilead Sciences, Inc. (US) | 2021-10-20 | — | — | EP | disclosed |